Neonatal intrahepatocellular lipid

E L Thomas1, S Uthaya, V Vasu

  • 1Molecular Imaging Group, MRC Clinical Sciences Centre, Imperial College London, London, UK.

Insights

Preterm birth elevates intrahepatocellular lipids (IHCL) in infants, a marker linked to adiposity-associated diseases. This finding suggests a potential mechanism connecting preterm birth to later metabolic health risks.

Area of Science:

  • Neonatology
  • Metabolic Health
  • Medical Imaging

Background:

  • Preterm birth is increasingly recognized as a risk factor for adiposity-associated diseases.
  • The underlying pathophysiology remains unclear.
  • Previous research indicated increased visceral adiposity in preterm infants by term-equivalent age.

Purpose of the Study:

  • To investigate intrahepatocellular lipid (IHCL) levels in preterm-born infants at term-equivalent age.
  • To compare IHCL levels between preterm-at-term infants, term-born infants, and adults.

Main Methods:

  • Quantitative measurement of IHCL using proton magnetic resonance spectroscopy ((1)H NMR).
  • Study cohort included 26 infants (8 healthy preterm-at-term, 18 term-born) and 32 adults as a reference group.

Main Results:

  • No significant difference in IHCL content was found between term-born infants and adults.
  • Preterm-at-term infants exhibited significantly elevated IHCL compared to both term-born infants and adults.
  • Median IHCL (CH2/water) values: preterm 1.69, term 0.21, adult 0.55.

Conclusions:

  • Infants born preterm have significantly higher intrahepatocellular lipid levels by term-equivalent age.
  • Elevated IHCL in preterm infants may represent an early indicator of metabolic alterations.
  • This finding provides a potential pathophysiological link between preterm birth and future adiposity-related health issues.